News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–121
Matches
121
Sources here
13
Companies here
1
Search results Stored financial headlines

Active search

121 matching headlines

Ticker or company: GEHCMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

HLTH Deals and strategy Main company 🇺🇸 United States

Catholic Health and GE HealthCare Form $500M Strategic Care Alliance to Modernize Imaging Infrastructure

Catholic Health and GE HealthCare have initiated a 10-year, $500 million strategic alliance to modernize imaging and diagnostic services across Long Island. This partnership will introduce over 1,300 pieces of advanced medical technology, including AI-enabled systems and GE HealthCare’s Imaging 360 platform, across Catholic …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Fierce Healthcare Deals and strategy Main company 🇺🇸 United States

GE HealthCare, Catholic Health strike 10-year, $500M technology partnership

GE HealthCare and Catholic Health have formed a 10-year, $500 million strategic partnership to equip the New York health system's facilities with advanced imaging, AI, and other technologies. This agreement, one of GE HealthCare's largest, will involve the rollout of over 1,300 new pieces …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MLQ.ai Earnings Main company 🇺🇸 United States

Frontier tech research, news & data

GE HealthCare Technologies Inc. (GEHC) reported an operating income of $2.76 billion in FY2025, an increase from $2.62 billion in FY2024. In the most recent quarter (Q1 FY26), its operating income was $515.0 million. The article provides a detailed breakdown of the company's operating …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Seeking Alpha Deals and strategy Main company 🇺🇸 United States

GE HealthCare inks $500M deal with Catholic Health (GEHC:NASDAQ)

GE HealthCare (GEHC) has signed a 10-year partnership agreement with Catholic Health, a New York-based healthcare system, worth approximately $500 million. This deal aims to modernize Catholic Health's operations in imaging, diagnostics, and AI-driven technology.

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Deals and strategy Main company 🇺🇸 United States

GE Healthcare, Catholic Health Sign $500 Million, 10-Year Partnership

GE Healthcare and Catholic Health have signed a 10-year, $500 million partnership aimed at modernizing healthcare delivery and improving patient outcomes in Western New York. The collaboration focuses on enhancing technology, driving innovation, and upgrading medical equipment across Catholic Health's facilities. This strategic alliance …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Bitget Deals and strategy Main company 🇺🇸 United States

GE HealthCare, Catholic Health enter 10-year Care Alliance valued at about $500 million

GE HealthCare and Catholic Health have formed a 10-year "Care Alliance" worth approximately $500 million. This partnership, announced by Reuters, will cover imaging equipment, digital platforms, AI technology, and services across over 40 sites, aiming to enhance healthcare access and efficiency, with about half …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
www.marketscreener.com Analyst action Main company 🇺🇸 United States

UBS Adjusts Price Target on GE Healthcare Technologies to $67 From $69, Maintains Neutral Rating

UBS has adjusted its price target for GE Healthcare Technologies (GEHC) to $67, down from $69, while maintaining a Neutral rating on the stock. This report from MT Newswires, published on July 16, 2026, highlights the change in analyst outlook for the medical equipment …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Carroll County Mirror-Democrat Deals and strategy Main company 🇺🇸 United States

Catholic Health and GE HealthCare partner to expand patient access across Long Island

Catholic Health and GE HealthCare have announced a 10-year, $500 million strategic partnership to expand patient access to advanced imaging, precision diagnostics, and AI-enabled technology across Long Island. This Care Alliance aims to modernize technology in key service lines like cardiology, oncology, neurology, and …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Deals and strategy Main company 🇺🇸 United States

GE HealthCare Partnership Plans 1,300 Tech Additions on Long Island

Catholic Health and GE HealthCare have announced a 10-year strategic Care Alliance valued at approximately $500 million to expand access to advanced imaging, precision diagnostics, and AI-enabled technology across Long Island. This partnership will introduce over 1,300 pieces of new technology to Catholic Health …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Simply Wall Street Earnings Main company 🇺🇸 United States

GE HealthCare (GEHC) Stock Trades Below Fair Value On Cash Flow And Earnings

GE HealthCare Technologies (GEHC) stock has declined 23.7% year-to-date, but both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples indicate it is currently trading at a discount. The DCF model suggests a 44% upside to the current price, valuing shares at …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketWatch Market update Main company 🇺🇸 United States

GE HealthCare Technologies Inc. stock rises Wednesday, outperforms market

GE HealthCare Technologies Inc. (GEHC) saw its stock rise by 2.50% to $63.20 on Wednesday, outperforming the broader market. The S&P 500 Index increased by 0.38% and the Dow Jones Industrial Average rose by 0.29% on the same day. Despite the gain, GE HealthCare …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TechTarget Regulatory and legal Main company 🇺🇸 United States

Healthcare ransomware attacks surge 14% amid growing cyberthreats

A new report by Comparitech indicates a 14% increase in healthcare ransomware attacks in the first half of 2026, totaling 410 incidents. This surge is primarily driven by attacks on healthcare businesses, while regulatory efforts to bolster cybersecurity have been postponed. The report highlights …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The Globe and Mail Earnings Main company 🇺🇸 United States

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Boston Scientific (BSX)

RBC Capital maintained a Buy rating on Tandem Diabetes Care (TNDM) with a price target of $30.00. TD Cowen maintained a Buy rating on Boston Scientific (BSX) with a price target of $61.00, while the general analyst consensus for Boston Scientific is a Strong …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context